Adult Mesenchymal Stem Cell Therapy in Joint Injury and Disease

Abstract

Frank Barry is the Director of Arthritis Research at Osiris Therapeutics, Inc., a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation.